Attending congresses is a strategic move for Oncopeptides, offering numerous benefits that align with our goals and mission. By attending, Oncopeptides not only fosters professional growth but also contributes significantly to the field of oncology, reinforcing our commitment to innovation and excellence.
Astrid Rydheim
astrid.rydheim@oncopeptides.com
Below we have listed the congresses that Oncopeptides will attend.
Date: April 3-5, 2025
Event: ESH – 5th How to Diagnose and Treat: Multiple Myeloma
Location: Vienna, Austria
Oncopeptides participation: Booth, Symposioum
Date: April 10-12, 2025
Event: 6th European Myeloma Network Meeting
Location: Athens, Greece
Oncopeptides participation: Booth
Date: May 15-18, 2025
Event: The 11th World Congress on Controversies in Multiple Myeloma (COMy)
Location: Paris, France
Oncopeptides participation: Booth?
Date: June 12-15, 2025
Event: 30th EHA Congress
Location: Milan, Italy
Oncopeptides participation: Booth?
For more information, please contact our Product Project Director:
Astrid Rydheim
astrid.rydheim@oncopeptides.com
Attending congresses is a strategic move for Oncopeptides, offering numerous benefits that align with our goals and mission. Here are some key reasons why we participate in these events:
Networking Opportunities: Congresses gather experts and professionals from various fields, providing a unique platform to make valuable connections, exchange ideas, and build relationships. These interactions can lead to future collaborations and career development opportunities.
Knowledge Exchange: By attending lectures, workshops, and panel discussions, we gain insights into the latest research findings, technologies, and trends in oncology. This knowledge helps us stay updated and continuously improve our skills and strategies.
Inspiration and Motivation: Listening to prominent speakers and engaging in discussions can spark new inspiration and motivation. These experiences offer fresh perspectives and ideas that we can apply to our work, driving innovation and excellence.
Professional Development: Many congresses offer certificates or credits that contribute to continuing education and professional development requirements. This is crucial for maintaining licenses and certifications, ensuring our team remains at the forefront of the field.
Marketing and Visibility: Presenting our research and projects at congresses enhances our visibility within the oncology community. It provides a platform to showcase our work, highlight our achievements, and market our organization to a broader audience.
Access to Resources: Congresses often feature exhibitions, publications, and specialized tools that are otherwise difficult to access. These resources are invaluable for our research and development efforts, supporting our mission to advance cancer treatment.
By attending congresses, Oncopeptides not only fosters professional growth but also contributes significantly to the field of oncology, reinforcing our commitment to innovation and excellence.